The tinnitus product Tinearity G1 has received market approval in the UK

2023-04-26 14:52

Today Tinearity G1 received certification for the UK, which means that the product has been approved for sale. The UK has the potential to be a significant market for Duearity as tinnitus is a problem that is widely recognized.

The market approval means that Duearity can start sales in the UK. Tinnitus is widely noticed in the UK and white noise, which is obtained using the Tinearity G1, is a method widely recommended by the profession.

Tinearity G1 is a non-invasive medical device that sends white noise to the inner ear with the aim of relieving tinnitus. The Tinearity G1 can also be used when a person is undergoing Tinnitus Retraining Therapy, which is the most recommended method of treating tinnitus.

For more information, please contact

Fredrik Westman, CEO
+46 738 - 145 215
fredrik.westman@duearity.com 
www.duearity.com

About Duearity AB (publ)

Duearity is a medtech company that develops and produces solutions aiming to relieve tinnitus symptoms and make everyday life easier for those who suffer from tinnitus. With a deep understanding of the people who have problems with tinnitus, the Company will with intelligent solutions give these people the opportunity to enjoy life. The company will offer the products Tinearity and Tinearity-AI. Tinearity transmits white noise using Bone Conduction Technology to the inner ear in order to relieve symptoms. Tinearity AI will use artificial intelligence to help people anticipate the symptoms and relieve their discomfort. The company's headquarters are located in Malmö, Sweden.
www.duearity.com.
www.tinearity.com

Attachments

The tinnitus product Tinearity G1 has received market approval in the UK